Analyst: Illumina's Takeover Clock Ticking

genomeweb
360dx

Analyst: Illumina's Takeover Clock Ticking

Apr 20, 2012

One year. That's how long Illumina CEO Jay Flatley has to prove he can increase his company's value beyond Roche's $6.7 billion takeover bid, Maxim Group analyst Bryan Brokmeier tells Bloomberg.

To read the full story....

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

Biocept Q2 Revenues Fall 37 Percent
Agilent Q3 Revenues Up 8 Percent
OncoCyte Net Loss Widens in Q2
Cell-Free DNA Screening, Invasive Testing Show Similar Miscarriage Rates, Study Suggests
Kromatid Receives $200K NHGRI Grant to Develop Single-Cell Structural Genomics Platform
Grifols Gets FDA Clearance for Procleix Zika Virus Assay

The Scan

Cell Count

NPR reports on Human Cell Atlas Consortium's effort to catalog all the different cell types within the human body.

Varied Opinions

The Union of Concerned Scientists surveyed US government scientists about Trump Administration policies and more, Science reports.

Marine Mammal Gene Loss

National Geographic reports that marine mammals have lost a gene that could make them more susceptible to organophosphate damage.

This Week in PNAS

In PNAS this week: history and genetic diversity of the scarlet macaw, approach for predicting human flu virus evolution, and more.

Main menu